FDA 510(k) FDA class 2 Substantially Equivalent 🇫🇷 France

Cellvizio 100 Series Systems with Confocal Miniprobes

K Number: K180270 · Decision May 22, 2018
Classifications
1
FEI Numbers
65
Registration Numbers
65
Same Product Code
92
Applicant Total
18
Review Days
111

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Cellvizio 100 Series Systems with Confocal Miniprobes
K Number
K180270
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
882.1480
Medical Specialty
Neurology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Mauna Kea Technologies
Date Received
January 31, 2018
Decision Date
May 22, 2018
Product Code
GWG
Advisory Committee
Neurology
Review Advisory Committee
NE
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GWG Endoscope, Neurological

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GWG), ordered by most recent decision date.

View all

Other Clearances by Mauna Kea Technologies

K Number Device Name
K220477 Cellvizio 100 series system with confocal Miniprobes
K212322 Cellvizio I.V.E. system with Confocal Miniprobes
K193416 Cellvizio I.V.E. with Confocal Miniprobes
K191144 Cellvizio 100 Series System with Confocal Miniprobes
K183640 Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes
K172844 Cellvizio 100 Series System with Confocal Miniprobes
K171345 Cellvizio 100 Series Systems with Confocal Miniprobes
K160416 CystoFlex UHD R-C, CelioFlex UHD 5-C, Cellvizio 100 Series (800) with Confocal Miniprobes
K150831 Cellvizio 100 Series System with Confocal Miniprobes
K151593 Cellvizio 100 Series System with Confocal Miniprobes
Search all 18 clearances from Mauna Kea Technologies →